fda compounding glp-1 warning letters september 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading U.S. Food & Drug Administration
Description
[GLP-1] .We manufacture and distribute chemical reagents for research use only or various antibodies.

167 million AFU

Mochi is a direct-to-consumer telemedicine platform offering GLP-1 medications for weight management

Learn why it happens and practical ways to manage it.
